Low glycemic sugar composition
US11898184B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Sep 7, 2017 |
| Grant date | Feb 13, 2024 |
| Priority date | — |
| Expiry date | Sep 7, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition includes a sugar source and inositol. The sugar source is one more sugars select from the group consisting of glucose, sucrose, sucrolose, tagatose, galactose, high fructose corn syrup, fructose, isoglucose, and rhamnose. The composition of sugar and inositol has an unique properties that prevents or limits the signaling of TNF-α and associated pro-inflammatory cytokines when metabolized by an individual consuming the composition. Accordingly, the composition can be advantageously used to control blood glucose levels, treat diabetes and related conditions as well as treat diseases based on an inflammatory response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.